PMID- 23009755 OWN - NLM STAT- MEDLINE DCOM- 20130531 LR - 20121231 IS - 1095-953X (Electronic) IS - 0969-9961 (Linking) VI - 50 DP - 2013 Feb TI - Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage. PG - 1-12 LID - S0969-9961(12)00322-1 [pii] LID - 10.1016/j.nbd.2012.09.008 [doi] AB - Norrin is a retinal signaling molecule which is expressed in Muller glia and binds to Frizzled-4 to activate canonical Wnt/beta-catenin signaling. Norrin is part of an essential signaling system that controls the formation of retinal capillaries during development. To evaluate neuroprotective properties of Norrin independently from its function during retinal angiogenesis, we generated transgenic mice (Rpe65-Norrin) that constitutively express Norrin in the retinal pigmented epithelium. Substantial amounts of Norrin were secreted into the outer retina, which triggered retinal Wnt/beta-catenin signaling in conjunction with an increase in the expression of endothelin-2 (EDN2), endothelin receptor B (EDNRB), and glial fibrillary acidic protein (GFAP). Photoreceptors of Norrin-overexpressing mice were significantly less vulnerable to light-induced damage compared to their wild-type littermates. Following light damage, we observed less apoptotic death of photoreceptors and a better retinal function than in controls. The protective effects were abolished if either Wnt/beta-catenin or EDN2 signaling was blocked by intravitreal injection of Dickkopf-1 or BQ788, respectively. Light-damaged retinae from transgenic mice contained higher amounts of brain-derived neurotrophic factor (BDNF) and pAkt than those of wild-type littermates. We conclude that constitutive overexpression of Norrin protects photoreceptors from light damage, an effect that is mediated by Wnt/beta-catenin and EDN2 signaling and involves neurotrophic activities of BDNF. The findings suggest that Norrin and its associated signaling pathways have strong potentials to attenuate photoreceptor death following injury. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Braunger, Barbara M AU - Braunger BM AD - Institute of Human Anatomy and Embryology, University of Regensburg, Universitatsstr. 31, D-93053 Regensburg, Germany. Barbara.Braunger@vkl.uni-regensburg.de FAU - Ohlmann, Andreas AU - Ohlmann A FAU - Koch, Marcus AU - Koch M FAU - Tanimoto, Naoyuki AU - Tanimoto N FAU - Volz, Cornelia AU - Volz C FAU - Yang, Ying AU - Yang Y FAU - Bosl, Michael R AU - Bosl MR FAU - Cvekl, Ales AU - Cvekl A FAU - Jagle, Herbert AU - Jagle H FAU - Seeliger, Mathias W AU - Seeliger MW FAU - Tamm, Ernst R AU - Tamm ER LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120923 PL - United States TA - Neurobiol Dis JT - Neurobiology of disease JID - 9500169 RN - 0 (Endothelin-2) RN - 0 (Eye Proteins) RN - 0 (Ndph protein, mouse) RN - 0 (Nerve Tissue Proteins) RN - 0 (Wnt Proteins) RN - 0 (beta Catenin) SB - IM MH - Animals MH - Blotting, Western MH - Endothelin-2/*metabolism MH - Eye Proteins/*metabolism MH - Light/adverse effects MH - Mice MH - Mice, Transgenic MH - Nerve Tissue Proteins/*metabolism MH - Photoreceptor Cells/*metabolism/pathology/radiation effects MH - Real-Time Polymerase Chain Reaction MH - Retina/metabolism/pathology/radiation effects MH - Reverse Transcriptase Polymerase Chain Reaction MH - Signal Transduction/*physiology/radiation effects MH - Wnt Proteins/*metabolism MH - beta Catenin/*metabolism EDAT- 2012/09/27 06:00 MHDA- 2013/06/01 06:00 CRDT- 2012/09/27 06:00 PHST- 2012/05/07 00:00 [received] PHST- 2012/09/12 00:00 [revised] PHST- 2012/09/15 00:00 [accepted] PHST- 2012/09/27 06:00 [entrez] PHST- 2012/09/27 06:00 [pubmed] PHST- 2013/06/01 06:00 [medline] AID - S0969-9961(12)00322-1 [pii] AID - 10.1016/j.nbd.2012.09.008 [doi] PST - ppublish SO - Neurobiol Dis. 2013 Feb;50:1-12. doi: 10.1016/j.nbd.2012.09.008. Epub 2012 Sep 23.